The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part II:: Treatment of mania

被引:133
作者
Grunze, H
Kasper, S
Goodwin, G
Bowden, C
Baldwin, D
Licht, RW
Vieta, E
Möller, HJ
机构
[1] Univ Munich, Dept Psychiat, D-80336 Munich, Germany
[2] Univ Vienna, Dept Gen Psychiat, Vienna, Austria
[3] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England
[4] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78285 USA
[5] Univ Southampton, Royal S Hants Hosp, Dept Mental Hlth, Southampton, Hants, England
[6] Aarhus Univ, Hosp Psychiat, DK-8240 Risskov, Denmark
[7] Hosp Clin Barcelona, Dept Psychiat, Barcelona, Spain
关键词
bipolar disorder; mania; acute treatment; evidence-based guidelines; pharmacotherapy; antipsychotics; mood stabiliser; electroconvulsive therapy;
D O I
10.3109/15622970309167904
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Identical to the preceding guidelines of this series, these practice guidelines for the biological, mainly pharmacological treatment of acute bipolar mania were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into four levels of evidence (A-D). As these guidelines are intended for clinical use, the scientific evidence was finally not only graded, but has also been commented by the experts of the task force to ensure practicability.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 28 条
  • [21] Guidelines for the biological treatment of bipolar depression
    Samalin, L.
    Charpeaud, T.
    Guillaume, S.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2011, 37 : S218 - S223
  • [22] Treatment of bipolar disorder part II: beyond guidelines, the science and the art of combining medication and psychoeducation in bipolar disorders
    E Vieta
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [23] Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision
    Soyka, Michael
    Kranzler, Henry R.
    Hesselbrock, Victor
    Kasper, Siegfried
    Mutschler, Jochen
    Moeller, Hans-Juergen
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2017, 18 (02) : 86 - 119
  • [24] French Society for Biological Psychiatry and Neuropsychopharmacology task force. Formal Consensus for the treatment of Bipolar disorder: An update (2014)
    Samalin, L.
    Guillaume, S.
    Courtet, P.
    Abbar, M.
    Lancrenon, S.
    Llorca, P. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 (01): : 93 - 102
  • [25] Recommendations of the Polish Psychiatric Association regarding the treatment of affective disorders in women of childbearing age. Part II: Bipolar disorder
    Rybakowski, Janusz
    Cubala, Wieslaw Jerzy
    Galecki, Piotr
    Rymaszewska, Joanna
    Samochowiec, Jerzy
    Szulc, Agata
    Dudek, Dominika
    PSYCHIATRIA POLSKA, 2019, 53 (02) : 263 - 276
  • [26] French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024
    Yrondi, Antoine
    Javelot, Herve
    Nobile, Benedicte
    Boudieu, Ludivine
    Aouizerate, Bruno
    Llorca, Pierre-Michel
    Charpeaud, Thomas
    Bennabi, Djamila
    Lefrere, Antoine
    Samalin, Ludovic
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2025, 51 (01): : 26 - 38
  • [27] Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental
    Bennabi, L. D.
    Charpeaud, T.
    Yrondi, A.
    Genty, J-B
    Destouches, S.
    Lancrenon, S.
    Alali, N.
    Bellivier, F.
    Bougerol, T.
    Camus, V
    Dorey, J-M
    Doumy, O.
    Haesebaert, F.
    Holtzmann, J.
    Lancon, C.
    Lefebvre, M.
    Moliere, F.
    Nieto, I
    Rabu, C.
    Richieri, R.
    Schmitt, L.
    Stephan, F.
    Vaiva, G.
    Walter, M.
    Leboyer, M.
    El-Hage, W.
    Llorca, P-M
    Courtet, P.
    Aouizerate, B.
    Haffen, E.
    BMC PSYCHIATRY, 2019, 19 (01)
  • [28] Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental
    D. Bennabi
    T. Charpeaud
    A. Yrondi
    J.-B. Genty
    S. Destouches
    S. Lancrenon
    N. Alaïli
    F. Bellivier
    T. Bougerol
    V. Camus
    J.-M. Dorey
    O. Doumy
    F. Haesebaert
    J. Holtzmann
    C. Lançon
    M. Lefebvre
    F. Moliere
    I. Nieto
    C. Rabu
    R. Richieri
    L. Schmitt
    F. Stephan
    G. Vaiva
    M. Walter
    M. Leboyer
    W. El-Hage
    P.-M. Llorca
    P. Courtet
    B. Aouizerate
    E. Haffen
    BMC Psychiatry, 19